Prostatic Diseases and Selenium

Date:2019-08-27 click:
According to statistics, 90% of men aged 18-80 suffer from prostatitis. 80% of men over 40 suffer from benign prostatic hyperplasia. 90.5% of men over 80 suffer from prostatic hyperplasia. Almost 50% of men over 80 suffer from prostate cancer lesions.
 
In the United States, the number of visits to benign prostate hyperplasia exceeds 2 million each year, the number of resections exceeds 400,000 per year, and one-fifth of patients need to undergo surgical treatment. However, according to the survey, only about one-third of the prostatic patients will seek diagnosis and treatments. Among them, there are numerous patients with serious diseases such as uremia, renal failure, myocardial infarction, and cerebral infarction caused by delayed treatment. 
 
In recent years, the onset age of prostatitis has also been gradually advanced, from the male who was mostly 20 to 65 years old to high school students. Prostatitis has become a male health killer. In fact, many drugs, such as Diuretic and Anti-inflammatory Pill, can achieve excellent results in the treatment of prostatitis. As long as males receive a scientific and regular treatment, there is no need to worry too much.
 
In the treatment of prostatitis, it was found that the selenium content in the prostatic fluid and seminal plasma of most people decreased, especially in patients with chronic prostatitis. Data show that the incidence of prostatic diseases in low selenium areas is much higher than that in high selenium areas, especially in cadmium workers.
 
Cadmium plays a vital role in the pathological evolution of prostate. With the increase of age and the influence of the environment, and selenium deficiency leads to endocrine disorders, which lead to prostate hyperplasia and even tumors caused by cadmium accumulation in the prostate. Selenium can inhibit the growth-promoting effect of cadmium on the human prostate epithelium, thus alleviating the disease.
 

New Comment
()

Submit Comment

Please leave a comment below with your questions and/or thoughts. All Comments are shown once approved by admin.
Name:*
Email:*
CAPTCHA:

Click me to change the verification code